Where our team of guest writers discuss what they think about the current NGP US Issues.

Untitled Document
Clinical Trial Performance Results:
Boomerang Pharmaceutical Communications, www.boomerangpharma.com, a consumer based Internet advertising agency, delivers a lower cost means to recruit patients for clinical trials. In just two weeks, Boomerang can set up a study specific website screener to reach patients and caregivers 24 hours a day, seven days a week.
The initial investment to the trial team is typically what the industry pays on average to recruit three patients into a Phase III trial. With the pharmaceutical industry estimating the average cost per Phase III patient recruited at $7,635, Internet savvy agencies are jumping in to find patients.
Today, more than 85 percent of U.S. patients’ research their medical conditions on the Internet, creating an accessible and motivated pool of potential trial study participants. Boomerang captures them at that exact moment, when they are motivated to act on their condition, and strives to get them to the investigator within 72 hours. The power of Internet targeting, the extremely high volume of visitors, the confidentiality of the web, the flexibility, and ability to give out trial information, lead to a more simple and gratifying approach.
Boomerang is unique in the patient recruitment arena in that they start by supplying an inexpensive website screener. When compared to the budget needed to staff a call center, create TV commercials, radio ads, or direct mail, this is truly a bargain. The website design incorporates ten years of best practices experience, and is positioned at consumers, not medical professionals. With a few simple mouse clicks, both parties know if the trial and potential patient are a good fit.
The website design should not be confused with those provided by ClinicalTrials.gov, Cancer.gov, Centerwatch.com, or the many provided by major Pharmaceutical companies. The content on those sites is confusing and frustrating for non-medical professionals to understand. Without the help of a health care provider, patients have no idea of whether or not they are eligible for trial participation. Furthermore, the average consumer has never even heard of those websites, as they are not advertised.
Launching a consumer recruitment website is just the beginning. The big challenge is to drive qualified patients to it, at a reasonable cost. This is where online expertise separates a certified expert from other traditional recruitment agencies. Performance metrics should be provided before the campaign, estimating a final cost for patient acquisition. Each advertised keyword should be analyzed to be sure that it is providing optimal results, leading back to patient randomizations.
How Search Engine Marketing Campaigns Work
Many search engines accept bids for certain keywords or keyword phrases. When a user enters this keyword phrase, an advertiser’s link, either in the form of a separate advertisement or a sponsored link, is displayed in a prominent position. In the case where two or more advertisers want to bid on the same keyword phrases, the higher bid will receive prominent positioning.
The links (at the top), and links in the right-hand column are sponsored listings, i.e. an advertiser has paid for these links to appear. The order in which the links appear depend on the amount the advertisers have bid for this keyword phrase; the higher the bid, the higher the position.
The bid amount is paid to the Search Engine (Yahoo, Google, MSN) each time a user clicks on the link.
Copywriters will create the initial text advertisements that appear when the chosen search terms are entered. The media company will submit the keywords and advertisement text to the media publishers for approval. Both Google and Yahoo have a number of rules about what can and can't appear in the text. For example, the text must be related to the keywords used, and the website or service advertised must be related to the keywords and advertisements.
Once the campaign begins, the sponsor must continually monitor the performance of each keyword and adjust the bids to maximize the visitor conversion rate and cost per click. In addition, the ads will be tracked to ascertain which ones are performing better, in terms of generating clicks and soft conversions, opt-ins of qualified patients for the study.
In addition to cost per click campaigning on Google and Yahoo, Boomerang targets patients who are already participating in a permission-based survey system, receptive to e-mail communication and who suffer from specific aliments. This generates a million more possibilities of finding participants per month. There are also banner ad placements to reach millions more.
Therapeutic Area Targeting
Even with a best in class patient recruitment screener, some therapeutic areas remain challenging. The Internet works best where consumers can determine their own eligibility. If the inclusion criteria are simple, such as recurrent prostate cancer, or first line lung cancer, you will have much more success. If the protocol requires a patient to understand their tumors’ particular pathology, like in oncology, the system is not successful yet.
Some areas that can work great include:
Boomerang does offer complete recruitment; incorporating traditional direct mail, radio TV, patient retention and site support. In addition, Boomerang has a unique relationship with active 55+ year-old senior centers to conduct live screening events and targeted promotions to one million monthly participants.
In addition to campaigning in the US, Boomerang has conducted some initial campaigns in Europe during 2007. Although it is more challenging, due to DTP regulatory constraints, with local resources working to insure IRB approvals, it can be done. Boomerang’s Headquarters is based in Mulhouse, France, so giving them global access and experience.
Questions you should ask your patient recruitment agency before using them to conduct an online campaign
Giles Day, Senior Director of the Targets and Mechanisms Informatics Group, Pfizer explains the three areas that he is focusing on to become more...
At the September 2007 NGP Discovery & Development Summit in Arizona,Anthony Ford-Hutchinson led a fascinating workshop on the prioritization of...
Dr. Thomas Chan, SVP of Discovery and Development at ArQule gives NGP his insight into what a small biotechnology company are concentrating on in the...
Dr. Richard Polisson is one busy man. As well as being the Senior Vice President of Clinical Research for Genzyme, overseeing the design and implementation of clinical...